Kenya To Make World’s First Pediatric TB Drug Available At National Level

Devex: Kenya will roll out the first child-friendly TB drug
“Kenya will become the first country to adopt and roll out at the national level the world’s first tuberculosis treatment for children next week. … The drug’s adoption in Kenya aims to correct a gap in TB treatment that frequently led to incorrect dosages and fueled drug-resistant strains of the disease. … The program comes through a partnership between WHO, Global Alliance for TB Drug Development, and UNITAID to develop and bring the drug through clinical trials, and will be implemented by the Kenyan government, local and international partners, including the Global Fund to Fight AIDS, Tuberculosis and Malaria…” (Anders, 9/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.